MORETTI, ARIANNA
MORETTI, ARIANNA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Development of a human immune system experimental model to investigate immune cells activation and targeting for CVD
2026 A. Moretti, S. Greco, A. Moregola, S. Della Bella, S. Balin, G.B. Vingiani, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
SREBP1c Modulates Treg Immunobiology Through a Phospholipid-Dependent Adenosine Pathway
2026 F. Bonacina, C. Procaccini, M. Iaia, A. Moretti, M. Svecla, S. Pedretti, J. Bogie, G.B. Vingiani, A. Moregola, F. Genova, C. Russo, G.D. Rosa, C.L. Rocca, G. Mondanelli, M. Gargaro, N. Mitro, G. Matarese, G.D. Norata
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.B. Vingiani, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.B. Vingiani, L. Gulla', M. Iaia, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.D. Norata, F. Bonacina
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis
2025 A. Moretti, S. Greco, A. Moregola, G.D. Norata, F. Bonacina
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases
2025 A. Moretti, S. Greco, A. Moregola, C.J. Binder, F. Porsch, G.D. Norata, F. Bonacina
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, G. Biagioli, J. Bojie, G.D. Norata, F. Bonacina
Role of STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) in the metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, G.D. Norata, F. Bonacina
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, J. Bojie, G.D. Norata, F. Bonacina
Engineering stem cells for immunomodulatory cell therapy of cardiovascular diseases
2024 A. Moretti, S. Greco, G.B. Vingiani, A. Moregola, E. Franchi, M. Busnelli, G.D. Norata, F. Bonacina
Engineering stem cells for immunomodulatory cell therapy of cardiovascular diseases
2024 A. Moretti, S. Greco, A. Moregola, E. Franchi, M. Busnelli, G.D. Norata, F. Bonacina
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells
2024 A. Moretti, A. Moregola, G. Biagioli, J. Bojie, G.D. Norata, F. Bonacina